ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,989Medicare Part D Prescriptions Filled, Including Refills

Rank: 182 out of 1006

$371K Total Retail Price of All Prescriptions

Rank: 376 out of 1006

441 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 441 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 441 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 7,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 485 457 1 3
SIMVASTATIN 372 355 2 1
LEVOTHYROXINE SODIUM 310 283 3 2
AMLODIPINE BESYLATE 300 293 4 4
ATENOLOL 284 283 5 13
LOSARTAN POTASSIUM 257 252 6 22
WARFARIN SODIUM 253 248 7 8
OMEPRAZOLE 235 222 8 9
HYDROCHLOROTHIAZIDE 219 210 9 11
METOPROLOL SUCCINATE 218 214 10 12
LOVASTATIN 210 185 11 44
FUROSEMIDE 208 192 12 6
CITALOPRAM HBR 184 158 13 24
DIOVAN 165 158 14 16
ATORVASTATIN CALCIUM 155 129 15 5
PREDNISONE 134 117 16 33
METFORMIN HCL 134 125 16 10
ZOLPIDEM TARTRATE 120 110 18 14
GLYBURIDE 117 105 R 19 65
PANTOPRAZOLE SODIUM 109 105 20 32
METOPROLOL TARTRATE 97 90 21 7
HYDROCODONE-ACETAMINOPHEN 84 68 S3 22 25
FLUOXETINE HCL 72 63 23 85
OXYCODONE-ACETAMINOPHEN 69 65 S2 24 57
ESCITALOPRAM OXALATE 68 65 25 27
TAMSULOSIN HCL 65 65 26 23
LABETALOL HCL 65 57 26 164
KLOR-CON M20 65 58 26 70
GABAPENTIN 64 59 29 20
DILTIAZEM 24HR ER 60 58 30 126
POTASSIUM CHLORIDE 59 54 31 30
PROPRANOLOL HCL 58 54 32 167
FLUTICASONE PROPIONATE 57 53 33 55
DIGOXIN 53 50 34 52
BUMETANIDE 52 48 35 204
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.